Chancellor Rachel Reeves Intends Specific Action on Living Costs in Forthcoming Budget
Chancellor Rachel Reeves has announced she is preparing "targeted measures to deal with cost of living challenges" in the forthcoming Budget.
Speaking to media outlets, she emphasized that reducing price rises is a joint responsibility of both the government and the central bank.
The United Kingdom's price growth is forecast to be the most elevated among the G7 advanced economies this calendar year and next.
Possible Energy Cost Measures
Reports indicate the administration could intervene to lower utility costs, such as by reducing the current 5% level of value-added tax applied on energy supplies.
An additional option is to cut some of the government charges currently included in household expenses.
Fiscal Constraints and Analyst Predictions
The government will receive the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for such actions.
The consensus from the majority of experts is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her self-imposed borrowing rules.
Previously on Thursday, calculations showed there was a £22 billion gap for the chancellor to resolve, which is at the lower end of projections.
"It is a shared responsibility between the central bank and the administration to further reduce some of the sources of price increases," Reeves stated to reporters in Washington, at the conferences of the IMF and global financial institution.
Revenue Pledges and Global Issues
While much of the attention has been on expected tax increases, the chancellor said the latest figures from the fiscal watchdog had not altered her pledge to manifesto promises not to raise rates on income tax, VAT or National Insurance.
She attributed an "uncertain global environment" with increasing geopolitical and commercial concerns for the fiscal tax moves, likely to be targeted on those "wealthiest."
International Economic Tensions
Addressing concerns about the UK's economic relations with China she said: "Our national security always take priority."
Recent announcement by China to increase export controls on critical minerals and other materials that are essential for advanced tech manufacturing led US President the US President to suggest an additional 100% tariff on goods from the Asian country, raising the prospect of an full-scale commercial conflict between the two largest economies.
The US Treasury Secretary described the Chinese action "commercial pressure" and "a global supply chain power grab."
Questioned on accepting the American proposal to participate in its dispute with China, Reeves said she was "very concerned" by Chinese measures and urged the Beijing authorities "to avoid restrictions and limit trade."
She said the move was "bad for the world economy and generates additional challenges."
"It is my opinion there are areas where we must challenge China, but there are also significant opportunities to export to China's economy, including financial services and other sectors of the economic system. We've got to maintain that balance appropriate."
The chancellor also stated she was cooperating with other major economies "regarding our own essential resources approach, so that we are less reliant."
Health Service Drug Costs and Funding
The Chancellor also acknowledged that the cost the NHS spends on drugs could increase as a result of current discussions with the US government and its drugs companies, in return for reduced taxes and investment.
Some of the biggest global drug companies have said recently that they are either delaying or scrapping projects in the UK, with some attributing the low prices they are receiving.
Last month, the government science advisor said the cost the health service spends on medicines would need to increase to stop businesses and pharmaceutical investment departing from the United Kingdom.
The Chancellor stated to media: "It has been observed as a result of the payment system, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other EU nations."
"Our aim is to guarantee that patients receiving care from the National Health Service are able to access the best life-saving treatments in the globe. And so we are examining all of that, and... seeking to secure additional investment into the UK."